Edward Schutter

Edward J.
Schutter is the founder of Ventrus Biosciences, Inc., Arbor Pharmaceuticals LLC.
Current positions include Chief Executive Officer at NitroMed, Inc., Director at Tidal Vision Products, Inc., Director at Vitruvias Therapeutics, Inc. since 2018, Director at Establishment Labs SA since 2016, Executive Director & Founding Member at Bio, Independent Non-Executive Director at Establishment Labs Holdings, Inc. since 2015, Independent Director at Terrascend Corp.
since 2020, and Director at Intrance Medical Systems, Inc. since 2022.
Former roles include President & Chief Executive Officer at Arbor Pharmaceuticals, Inc. from 2010 to 2021, Chairman at Center for Global Health Innovation, Inc., Director at Vensun Pharmaceuticals, Inc., Director at Knight Therapeutics, Inc., Director at Mercer University, Managing Director at XenoPort, Inc., Director at American Diabetes Association, Vice President-Global Business Development at Solvay SA from 2002 to 2006, President & Chief Operating Officer at Shionogi Pharma, Inc. from 2007 to 2009, Vice President-Global Business Development at Solvay Pharmaceuticals, Inc. from 1990 to 2005, Trustee at American Heart Association, Inc., Vice President-Global Business Development at Abbott Products Operations AG, and President at Sciele Pharmaceuticals, Inc. from 2006 to 2009.
Education includes undergraduate studies at Mercer University, an MBA from Kennesaw State University, and graduate studies at Nyenrode Business Universiteit.